OBJECTIVE: Type 2 diabetes mellitus (T2DM) is known to be related to increased arterial stiffness. However, little is known about the risk of T2DM due to accelerated arterial stiffness and the underlying mechanism involved. We aimed to examine arterial stiffness, as determined by branchial-ankle pulse wave velocity (baPWV), in relation to diabetes mellitus among a community-based population and whether the association was mediated by white blood cell (WBC) counts.
glucose (IFG). 5, 6 Moreover, increased arterial stiffness was reported to be a significant predictor of allcause mortality and cardiovascular morbidity in T2DM patients. 7 Interestingly, it has also been postulated that microvascular alterations accompanying the arterial stiffening may dysregulate glucose metabolism, and further exacerbate the development of T2DM. 8 However, few studies to date have investigated the relation of accelerated arterial stiffness with T2DM risk. Very recently, Muhammad et al 9 observed that increased arterial stiffness was associated with incidence of T2DM in an apparently healthy elderly population, but the underlying mechanisms connecting the 2 entities remain to be clarified.
Except for oxidative stress and endothelial dysfunction, 5, 10 changes in white blood cell (WBC) count, a marker of systemic inflammation, may represent an intermediate step linking arterial stiffness to T2DM. 11, 12 Arterial stiffness is a reflection of adverse structural and functional changes in the arterial walls, which may result in endothelial dysfunction and accompanying proinflammatory state, such as WBC count elevation. 13, 14 Increased arterial stiffness is significantly correlated with elevated total or differential WBC counts in several previous studies. 15, 16 Meanwhile, elevated total and/or differential WBC counts have also been linked with incidence of T2DM in a populationbased cohort study. 17 Therefore, it is possible that arterial stiffness may facilitate the development of T2DM via altered WBC counts. However, no study has been conducted to examine the potential role of WBC counts as a mediator in the association between accelerated arterial stiffness and T2DM risk.
Branchial-ankle pulse wave velocity (baPWV) is a novel and noninvasive measure for arterial stiffness of central and peripheral arteries. To address the current knowledge gap, we aimed to examine (1) the cross-sectional association between increased arterial stiffness, as determined by baPWV and risk of T2DM among an urban community of middle-aged and elderly Chinese adults; (2) the mediating effect of total and differential WBC counts on this potential relationship.
MATERIALS AND METHODS
The data that support the findings of this study are available from the corresponding author upon reasonable request.
Study Population
We recruited 1301 community residents aged >18 years from the Baofeng community of Qiaokou district in Wuhan city, China between July 2017 and November 2017. The residents had lived in the community for >2 years and did not think about moving in the next years. The primary aim of the communitybased observational study was to (1) describe the prevalence of common chronic diseases with focus on T2DM and hypertension; and (2) examine the effects of lifestyle, diet, psychosocial, occupational and environmental factors, and biochemical factors on T2DM and hypertension.
The minimum required sample size (n=865) was estimated based on the average prevalence of T2DM among Chinese adults of 10% and a relative precision of 2%. In this study, we excluded participants who had missing information on fasting glucose (n=30) or baPWV (n=54). In addition, we also excluded individuals who had serious health conditions such as coronary heart disease (n=113), stroke (n=38), or cancer (n=30), as those with these chronic conditions might already have abnormal baPWV levels, thus overestimate the baPWV-T2DM association. After exclusion, a total of 1036 participants remained eligible in the present study. A flow chart showing the study procedure is shown in Figure I in the online-only Data Supplement. The protocol was reviewed and approved by the Ethics and Human Subject Committee of Tongji Medical College, and written informed consent was obtained from each participant before the study began.
Measurement of baPWV
The measurement of baPWV was performed by using an oscillometric device (form PWV/ABI, BP-203RPEIII; Omron, Kyoto, Japan). Participants were kept in supine position for at least 5 to 10 minutes. The device simultaneously records left and right brachial and tibial arterial waveforms, lead I of an ECG, and a phonocardiogram. Occlusion cuffs, which were connected to both plethysmographic and oscillometric sensors, were positioned around both arms and ankles of the subject for blood pressure measurements and pulse wave analysis. The baPWV was automatically calculated as the distance from the heart to ankle minus the distance from the Nonstandard Abbreviations and Acronyms baPWV branchial-ankle pulse wave velocity IFG impaired fasting glucose T2DM type 2 diabetes mellitus WBC white blood cell Highlights • Increased branchial-ankle pulse wave velocity was dose-responsive associated with elevated risk of type 2 diabetes mellitus, and the association was more evident in individuals with overweight/obese than in subgroups with normal weight. • Significant dose-dependent relationships were found across branchial-ankle pulse wave velocity tertiles with increasing total and/or differential white blood cell counts, which in turn, were positively related to higher risk of type 2 diabetes mellitus. • Total white blood cell count mediated a modest but significant proportion of the association between increased branchial-ankle pulse wave velocity and elevated type 2 diabetes mellitus risk.
heart to brachium (D) divided by the time difference between the brachial and ankle arterial pressure wave (ΔT), and the mean value of the left and right baPWV was included in the final analysis. The baPWV measurements were repeated in 143 study participants within 60 days to assess the shortterm reproducibility. The intraclass correlation coefficient of baPWV between repeated measurements was 0.80, indicating good reproducibility (intraclass correlation coefficient >0.75) of the baPWV measures for subjects over short periods. The Bland-Altman plot further showed good consistence between the 2 measurements, and most of the difference between the 2 measurements ranged ±2 SD from the mean ( Figure II in the online-only Data Supplement).
Assessment of Covariates
Details on the assessment of covariates are provided in the online-only Data Supplement.
Definition of Normal Glucose, IFG, and T2DM
Details on the definition of normal glucose, IFG, and T2DM are provided in the online-only Data Supplement.
Statistical Analysis
Basic characteristics of the participants across each tertile of baPWV were described as mean±SD, or median (interquartile range), depending on the normality of the continuous variables, or as number (percentage) for categorical variables. Tests for linear trend were computed by using the median value of baPWV for each tertile modeled as a continuous variable. We applied 2 logistic regression models to estimate the odds ratio and 95% CI for IFG or T2DM risk associated with increased baPWV tertiles. Model 1 was adjusted for age and sex, and model 2 was further adjusted for other covariates, as shown in Table 2 . Stratified analyses between baPWV and T2DM were conducted by basic characteristics, including age (<60 and ≥60 years), sex (male, female), body mass index (<24, ≥24 kg/ m 2 ), smoking status (never, ever), drinking status (never, ever), hypertension (no, yes), and hyperlipidemia (no, yes). Generalized linear regression models were performed to assess the relationships of baPWV tertiles with total and differential WBC counts. In addition, multivariate logistic regression models were applied to estimate the effects of total and differential WBC counts on T2DM risk. To determine whether total or differential WBC counts could mediate the effect of increased baPWV on the risk of T2DM, we conducted a mediation analysis to calculate the proportion mediated and test its significance using the R package for causal mediation analyses. 18 All analyses were performed using SAS version 9.4 (SAS Institute, Inc, Cary, NC) or R software (version 3.5.0; R Foundation for statistical computing, Austria). A 2-side P<0.05 was considered to be statistically significant.
RESULTS

Characteristics of the Study Population
General and clinical characteristics of the subjects by tertiles of baPWV are presented in Table 1 . Among the population, the mean (±SD) age of the population was 64.3±12.2 years, 58% were females,19.4% had T2DM, and 12.5% had IFG (see Table 2 ). Participants with higher baPWV were older, had higher levels of education, heart rate, mean arterial pressure, and were more likely to have hypertension. In addition, elevation of baPWV tertiles was significantly correlated with higher total and differential WBC counts (all P for trend <0.001).
Relationship Between baPWV and Risk of T2DM
As shown in Table 2 , we found increasing tertiles of baPWV were associated, in a dose-dependent manner, with an elevated risk of T2DM after adjustments for age and sex in model 1 (P for trend =0.001 
Stratified Analyses for the Association Between baPWV and T2DM
We subsequently performed stratified analyses by major characteristics of the study population ( Table II in the online-only Data Supplement). Body mass index modified the positive association between elevated baPWV levels and T2DM risk, and the association was more evident in individuals with overweight/obese than in subgroups with normal weight (P for interaction =0.055).
Conversely, a similar significant association between baPWV and T2DM persisted irrespective of hypertension status (P for interaction =0.020).
Association of baPWV With Total and Differential WBC Counts
The relations of baPWV with total and differential WBC counts based on linear regression models are presented in Table 3 . After multivariable adjustment, we observed significant dose-dependent relationships between higher baPWV and increasing total WBC and basophil count (P for trend=0.014 and 0.020, respectively). The participants in the T3 of baPWV showed a significantly elevated total WBC (β, 0.34 [95% CI, 0.07-0.61]) and basophil count (β, 0.16 [95% CI, 0.03-0.29]), compared with those in the T1.
Association of Total and Differential WBC Counts With T2DM Risk
As shown in Table 4 , we found that total and differential WBC counts were associated, in a dose-responsive manner, with increased risk of T2DM. Compared with subjects in the T1 of total WBC counts, neutrophil count, and monocyte count, those in the T3 had a 54% to 68% increased risk of T2DM (P for trend =0.048, 0.033, and 0.024, respectively).
Mediation Analyses
A mediator should be linked to both the exposure and the outcome. 19 To further test the potential mediating effects of total and differential WBC counts on the baPWV-T2DM association, we conducted causal mediation analysis. After controlling for possible confounders, significant mediation was observed for the association between baPWV and T2DM risk by total WBC counts (estimated proportion mediated, 4.5%; P<0.05; Table 5 ).
DISCUSSION
The results of this observational, community-based study demonstrated that elevated baPWV was associated with a higher risk of T2DM in a dose-responsive manner. Furthermore, we observed significant dosedependent associations between baPWV and total and differential WBC counts, as well as total and differential WBC counts and T2DM risk. Assuming that the mediating effects were valid, our data indicated that total WBC mediated 4.5% of the association between elevated baPWV levels and T2DM risk. It is already known that arterial stiffness is increased with the presence of T2DM, but the notion of arterial Values are mean±SD, n (%), or median (IQR). Mean arterial pressure=(systolic blood pressure+2×diastolic blood pressure)/3. baPWV indicates branchial-ankle pulse wave velocity; BMI, body mass index; IQR, interquartile range; and WBC, white blood cell. *A total of 5 subjects had missing information on total WBC count; 60, on neutrophil count; 38, on lymphocyte count; 62, on monocyte count, eosinophil count, and basophil count. stiffness as a key component in the pathogenesis of T2DM has not been well elucidated. In support of our results, Yasuno et al 20 previously observed that increased pulse pressure (a crude surrogate index of arterial stiffness) was an independent predictor of incident T2DM among 2685 high-risk Japanese hypertensive patients. More recently, Muhammad et al 9 reported a positive relationship between arterial stiffness, as determined by carotid-femoral pulse wave velocity, and new-onset T2DM in 2450 elderly individuals. However, it should be noted that the measure carotid-femoral pulse wave velocity is more complex to apply to clinical practice and causes poor reproducibility; hence, it is not suitable for general population studies. 21 The present study added to the existing evidence by demonstrating for the first time that baPWV, a novel and noninvasive measurement of arterial stiffness, was positively correlated with risk of T2DM among general Chinese adults, which might have significant public health implications for the prevention and control of diabetes mellitus epidemic.
Although IFG is predictive of subsequent diabetes mellitus risk, we found no evidence of association between baPWV and IFG. In agreement with our finding, Li et al 22 failed to show a significant relation of isolated IFG with baPWV elevation after multivariate adjustments among 4938 relatively healthy Chinese adults. It is possible that arterial dysfunction may be present before hyperglycemia becomes evident, but obviously whether there is any association here has no time element because of the cross-sectional analysis.
Interestingly, the association between arterial stiffness and T2DM seemed to be more evident among overweight or obese individuals. Although the underlying mechanism that accounts for the characteristics difference remains inconclusive, accumulating evidence supports the role of vascular stiffness in impaired tissue perfusion, especially among obese subjects. 23, 24 In overweight or obese individuals, the endocrine pancreas fails to secrete enough insulin to meet the metabolic demand, which may promote β-cell failure due to the acquired insulin secretory dysfunction or decreased β cell mass. 25 In obesity, accumulation of inflamed perivascular adipocytes may conceivably contribute to systemic inflammation, thereby augmenting atherosclerosis and insulin resistance. 26 Taken together, it can be speculated that arterial stiffness has the potential to disturb glucose homeostasis by introducing impaired tissue perfusion, which may be exacerbated by obesity.
WBC count, a routinely available marker of inflammation, is known to be involved in the process of vascular damage and atherosclerosis. 27 Numerous epidemiological studies have indicated that elevated total and differential WBC counts, even within the normal range, were significantly related to arterial stiffness and higher risk of incident coronary heart disease. 11, 28 Arterial stiffness and WBC count may be linked by a subclinical inflammation in the vessel wall. Additionally, stimulated WBCs drive the generation of reactive oxygen species and cytokines release, which may contribute to further vascular damage. 29 Meanwhile, compelling evidence between total or differential WBC counts and T2DM risk have been reported in prior epidemiological studies. 30 Therefore, elevated WBC count, a simple reflection of low-grade inflammation, may play a crucial role in the development of T2DM caused by arterial stiffness. Interestingly, our mediation analysis showed that total WBC count mediated a modest but significant proportion (4.5%) of the above-mentioned association, suggesting that chronic inflammation plays an intermediating role. Nevertheless, our results should be interpreted cautiously, the mediation analysis is useful, but as yet, it is not untangled from other earlier indices because the design is cross-sectional.
Our findings were subjected to several limitations. First, it had a cross-sectional design, which did not allow us to establish a causal relationship between elevated baPWV levels and risk of T2DM. Secondly, it is likely that another inflammatory marker (such as C-reactive protein) was also related to both arterial stiffness and T2DM risk. However, we only measured 6 total and differential WBC counts as potential mediators in the present study and did not adjust for other unmeasured inflammatory markers, limiting a comprehensive assessment of the mediating effects of inflammatory markers in the association between arterial stiffness and T2DM risk. The much fewer numbers of differential WBC counts might also limit statistical ability to detect differences. In addition, the use of single measurement of fasting glucose and the inability to link arterial stiffness data on oral glucose test may result in an underestimation of T2DM prevalence in this population. Finally, the results of the present study are confined to middle-aged and elderly Chinese adults, and thus, the findings may not be generalized to people of all ages, different health conditions, or other ethnicities.
In summary, we found a significant association between increased baPWV and higher risk of T2DM among middle-aged and older adults. The association could be partially mediated by elevated total WBC count. Our study highlights a mediating role of WBC counts in Adjusted for age, sex, BMI, smoking status, drinking status, physical activity, education, hypertension, hyperlipidemia, heart rate, mean arterial pressure, and family history of diabetes mellitus. BMI indicates body mass index; OR, odds ratio; T2DM, type 2 diabetes mellitus; and WBC, white blood cells.
Table 5. Mediation Effect Investigating Whether Total and Differential WBC Counts Mediated the Association Between baPWV and Risk of T2DM
Mediators
Direct Effect (95% CI) Indirect Effect (95% CI) Percent Mediated (%)
Total WBC count 0.061 (0.040 to 0.070)* 0.003 (0.001 to 0.010)* 4.5
Neutrophil count 0.063 (0.044 to 0.070)* 0.002 (−0.001 to 0.010) 2.3
Lymphocyte count 0.063 (0.039 to 0.080)* 0.001 (−0.004 to 0.010) 0.9
Monocyte count 0.066 (0.045 to 0.080)* 0.002 (−0.001 to 0.010) 2.0 Eosinophil count 0.068 (0.048 to 0.080)* −0.000 (−0.004 to 0.000) 1.3
Basophil count 0.056 (0.022 to 0.090)* 0.005 (−0.069 to 0.070) 6.4
Adjusted for age, sex, BMI, smoking status, drinking status, physical activity, education, hypertension, hyperlipidemia, heart rate, mean arterial pressure, and family history of diabetes mellitus. baPWV indicates branchial-ankle pulse wave velocity; BMI, body mass index; T2DM, type 2 diabetes mellitus; and WBC, white blood cells. *P<0.05.
